Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine composition for injecting triamcinolone acetonide palmitate lipid microsphere and preparation method thereof

A technology of palmitate and lipid microspheres, applied in the field of medicine, can solve the problems of drug precipitation, pain, human toxicity, etc.

Inactive Publication Date: 2008-12-31
GUANGZHOU PUIS PHARMA FACTORY
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Triamcinolone acetonide palmitate is triamcinolone acetonide-21-palmitate, which has little solubility in water, but is highly fat-soluble, but has slightly less solubility in common vegetable oils. If you choose common vegetable oils, triamcinolone acetonide When palmitate is made into a pharmaceutical composition for lipid microsphere injection, there may be problems such as drug precipitation during dilution, pain at the injection site or phlebitis, and toxicity of additives to the human body.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition for injecting triamcinolone acetonide palmitate lipid microsphere and preparation method thereof
  • Medicine composition for injecting triamcinolone acetonide palmitate lipid microsphere and preparation method thereof
  • Medicine composition for injecting triamcinolone acetonide palmitate lipid microsphere and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0130] The composition and preparation process of each component in the pharmaceutical composition for injection of triamcinolone palmitate lipid microspheres per 100ml

[0131] composition:

[0132] Triamcinolone Palmitate 10%

[0133] Soybean Oil 25%

[0134] Medium Chain Fatty Acid Triglycerides 15%

[0135] Soy Lecithin 6.4%

[0136] Tween-80 0.8%

[0137] F68 1.0%

[0138] Glycerin 6.5%

[0139] EDTA0.5%

[0140] Sodium Oleate 0.1%

[0141] Appropriate amount of pH adjuster

[0142] The rest is water for injection.

[0143] Preparation:

[0144] (1) Mix the prescribed amount of glycerin, Tween-80, F68, EDTA, sodium oleate with water for injection preheated to 80°C, and stir until the ingredients are dissolved to obtain the aqueous phase;

[0145] (2) adding the prescribed amount of soybean lecithin and triamcinolone acetonide palmitate to the oily medium of soybean oil and medium-chain fatty acid triglycerides and mixing, heating to 80° C., and magnetically sti...

Embodiment 2

[0151] The composition and preparation process of each component in the pharmaceutical composition for injection of triamcinolone palmitate lipid microspheres per 100ml

[0152] Triamcinolone Acetonide Palmitate 0.01%

[0153] Soybean Oil 2.0%

[0154] Medium Chain Fatty Acid Triglycerides 1.5%

[0155] Soy Lecithin 0.5%

[0156] Tween-80 0.05%

[0157] F68 0.05%

[0158] Glycerin 2.25%

[0159] EDTA0.02%

[0160] Sodium Oleate 0.01%

[0161] Appropriate amount of pH adjuster

[0162] The rest is water for injection.

[0163] Preparation:

[0164] Use the components and their dosages of this example to prepare according to the same preparation method as in Example 1.

Embodiment 3

[0166] The composition and preparation process of each component in the pharmaceutical composition for injection of triamcinolone palmitate lipid microspheres per 100ml

[0167] Triamcinolone Acetonide Palmitate 0.2%

[0168] Soybean Oil 7.5%

[0169] Medium Chain Fatty Acid Triglycerides 5.0%

[0170] Soy Lecithin 3.5%

[0171] Tween-80 0.8%

[0172] F68 0.6%

[0173] Glycerin 0.5%

[0174] Sodium Oleate 0.06%

[0175] Appropriate amount of pH adjuster

[0176] The rest is water for injection.

[0177] Preparation:

[0178] The components and their dosages of this example were used to prepare according to the same preparation method as that of Formulation Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the medical technical field, in particular to a lipid microsphere injection medical combination containing triamcinolone palmitate and a preparation method thereof.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a pharmaceutical composition for lipid microsphere injection containing triamcinolone acetonide palmitate and a preparation method thereof. Background technique [0002] Triamcinolone acetonide is a long-acting glucocorticoid drug with strong and long-lasting anti-inflammatory and anti-allergic effects. It is mainly used to treat various skin diseases, immune diseases, bronchial asthma, frozen shoulder, tenosynovitis, acute sprains, chronic low back pain and eye diseases, etc. Because of its remarkable curative effect, the scope of clinical application continues to expand. At present, the formulations of triamcinolone acetonide that have been listed include triamcinolone acetonide aerosol, triamcinolone acetonide oral ointment, triamcinolone acetonide gel, triamcinolone acetonide econazole cream, although such external dosage forms have strong Inflammation effect, but long-ter...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/127A61K31/58A61P29/00A61P37/08
Inventor 贝庆生
Owner GUANGZHOU PUIS PHARMA FACTORY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com